跳至主要内容
临床试验/NL-OMON39871
NL-OMON39871已完成不适用

TRough vs AUC Monitoring of cyclosporine: A randomized comparison of adverse drug reactions in allogeneic stem cell recipients (TRAM-study) - TRAM study

Vrije Universiteit Medisch Centrum0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Age 18-65 inclusive
  • * AML, MDS, ALL, MM, CML, CLL, NHL, HL, or a myeloproliferative disease (MPD)
  • * Planned allogeneic stem cell transplantation
  • * Related or unrelated donor with a 7/8 or 8/8 HLA match (HLA A, B, C, DRB1) or 9/10 or 10/10 MUD match
  • * WHO performance status 0-2

排除标准

  • * Renal dysfunction (serum creatinine > 150 umol/L or clearance < 50 ml/min)
  • * Patients with active, uncontrolled infection
  • * Cord Blood transplantation
  • * Patients with progressive disease in case of MM, CLL, NHL, HL
  • * Patients with > 5% marrow blasts in case of AML, ALL, CML
  • * Patients with EMD in case of AML, ALL, CML

研究者

相似试验